Effect of topical tranexamic acid in open heart surgery
Authors:
- K. M. AbdullahKAK. M. Abdullah
- 1 May 2006
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 23 (5) , 380-384
Abstract
Cardiopulmonary bypass is known to induce postoperative coagulopathy including fibrinolysis. We have evaluated the effect of the topical use of tranexamic acid in the pericardial cavity on postoperative bleeding following open heart surgery. One hundred patients, scheduled for elective open heart surgery, were included in this double-blind, prospective, randomized, controlled study. They were allocated to a treatment group (Group I), or placebo group (Group II). Patients with coagulopathies, renal failure, re-do surgery, or recent anti-platelet treatment were excluded. In Group I, tranexamic acid (2 g in 100 mL of saline solution) was poured into the pericardial cavity before sternal closure. Placebo patients received 100 mL of saline. Postoperative blood loss, need for transfusion of blood products and the rate of re-sternotomy for bleeding were documented. During the first postoperative 24 h, cumulative blood loss was significantly higher in Group II compared to Group I (1208 +/- 121 mL vs. 733 +/- 93 mL, respectively) (P < 0.001). More blood transfusions were administered to Group II patients (4.54 +/- 1.4 units) as compared to Group I patients (2.64 +/- 1.5 units) (P < 0.01). Topical application of tranexamic acid in patients undergoing primary open heart surgery led to a significant reduction of both postoperative mediastinal bleeding, and rate of re-exploration for haemostasis.Keywords
This publication has 10 references indexed in Scilit:
- Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypassThrombosis and Haemostasis, 2004
- Topical use of tranexamic acid in coronary artery bypass operations: A double-blind, prospective, randomized, placebo-controlled studyThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Analyses of coronary graft patency after aprotinin use: Results from the international multicenter aprotinin graft patency experience (IMAGE) trialThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleedingThe Annals of Thoracic Surgery, 1994
- Topical aprotinin in cardiac operationsThe Annals of Thoracic Surgery, 1994
- Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass graftingThe Journal of Thoracic and Cardiovascular Surgery, 1994
- Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patencyThe Journal of Thoracic and Cardiovascular Surgery, 1994
- Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1993
- Topical use of aprotinin in open heart operationsThe Annals of Thoracic Surgery, 1993
- Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operationsThe Journal of Thoracic and Cardiovascular Surgery, 1993